PROFESSIONAL EDITION

The largest community of pharma leaders

Look Who’s On the Move!

Frank Neumann, M.D., Ph.D., to Depart Verastem Oncology

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the...

Talaris Therapeutics Adds Two Experienced Biotechnology Executives to its Board of Directors

BOSTON & LOUISVILLE, Ky.--(BUSINESS WIRE)--Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to induce durable immune...

Ipsen Appoints Gwenan White as Executive Vice President, Communications and Public Affairs

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment of Gwenan White as Executive Vice President, Communications and Public Affairs, effective...

CIRCULOGENE Appoints Stephen Unger Chief Financial Officer

BIRMINGHAM, Ala.--(BUSINESS WIRE)-- #cancer--CIRCULOGENE appoints life sciences industry investment and finance veteran Stephen Unger as Chief Financial Officer. Source Business Wire Health: Pharmaceutical NewsRead...

Nilesh Patel Joins Cellanyx Board of Directors

BEVERLY, Mass.--(BUSINESS WIRE)--Nilesh Patel, a private equity exec with a background in strategy, operations, analytics and corporate finance joins Cellanyx board of directors. Source...

SwanBio Therapeutics Appoints Alison Lawton to Board of Directors

PHILADELPHIA--(BUSINESS WIRE)--SwanBio Therapeutics (SwanBio), a gene therapy company advancing AAV-based therapies for the treatment of devastating, genetically defined neurological conditions, today announced the appointment...

Recent Articles